ARCHIVES

Decline In Breast Cancer May Be Related to Drop In HT

This article is from The Cancer Letter archive.

Vol. 34 No. 3 | March 25, 2011

Download PDF Visit The Full Archive

Related Articles

Perifosine, Sorafenib Combination Well Tolerated in Several Lymphomas

December 28, 2012

FDA Forms Office of Combination Products;

January 10, 2003

In Brief: Guide Is Late, So RFP Deadline Extended; Real Cancer Mortality Increase Was .7%

January 28, 1977

Obituary: Patricia Delaney, FDA Cancer Liaison.

June 6, 2008

NCI-Approved Clinical Trials

May 28, 2004

Bennett, CCIRC Members Disagree On state Of Groups, Simons New Chairman

June 27, 1980